FDA Panel Will Review Zogenix's Zohydro on Dec. 7th; Catalyst Says CPP-109 …

Published November 15, 2012

FDA Panel Will Review Zogenix's Zohydro on Dec. 7th; Catalyst Says CPP-109 …
Filed under: gabapentin cocaine abuse
Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use of CPP-109 (vigabatrin) to treat cocaine addiction. …. XenoPort, Inc. (Nasdaq:XNPT) announced today that it … Read more on Equities.com

Medicinal marijuana offers 'medical alternative'
Filed under: gabapentin cocaine abuse
"It's really important that the pending bills pass, because it would demonstrate a big step in American progressive thinking," said Berkeley Byers, President of West Virginia University's Students for a Sensible Drug Policy organization. "It's not … Read more on The Daily Athenaeum